Lasa Supergeneri

17
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
4.33
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 50.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -82.35% vs 36.53% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -217.56% vs 189.32% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -85.66% vs 39.37% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -131.01% vs 32.09% in Mar 2025

Compare Profit and Loss Results of Lasa Supergeneri
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
25.00
14.00
11.00
78.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
25.00
14.00
11.00
78.57%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
0.00
4.00
0%
Raw Materials Consumed
19.00
10.00
9.00
90.00%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
2.00
1.00
1.00
100.00%
Operating Expenses
2.00
1.00
1.00
100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
32.00
13.00
19.00
146.15%
Operating Profit (PBDIT) excl Other Income
-7.00
0.00
-7.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
-7.00
1.00
-8.00
-800.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
-7.00
1.00
-8.00
-800.00%
Depreciation
6.00
0.00
6.00
0%
Profit Before Taxation & Exceptional Items
-13.00
1.00
-14.00
-1,400.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-34.00
1.00
-35.00
-3,500.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-34.00
0.00
-34.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-61.00
7.00
-68.00
-971.43%
Profit Available for appropriations
-95.00
8.00
-103.00
-1,287.50%
Appropriations
-95.00
8.00
-103.00
-1,287.50%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-6.8
2.6
-9.40
-361.54%
Profit And Loss - Net Sales
Net Sales 25.14 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -82.35% vs 36.53% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -7.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -217.56% vs 189.32% in Mar 2025

Profit And Loss - Interest
Interest 0.39 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -85.66% vs 39.37% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax -34.09 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -131.01% vs 32.09% in Mar 2025